
NeoGenomics (NASDAQ:NEO) brought in sales totaling $125.73 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 105.22%, resulting in a loss of $41.76 million. In Q3, NeoGenomics brought in $121.34 million in sales but lost $20.35 million in earnings.